Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Pharmacokinetics
Interventions
DRUG

levothyroxine

DRUG

levothyroxine

Trial Locations (1)

69120

Clinical Research Unit, University of Heidelberg, Heidelberg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi-Synthelabo

INDUSTRY

lead

Heidelberg University

OTHER